<VariationArchive VariationID="13069" VariationName="NM_000321.3(RB1):c.2520+1del" VariationType="Deletion" Accession="VCV000013069" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-02" DateCreated="2013-04-04" MostRecentSubmission="2024-06-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28108" VariationID="13069">
      <GeneList>
        <Gene Symbol="RB1" FullName="RB transcriptional corepressor 1" GeneID="5925" HGNC_ID="HGNC:9884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48303751" stop="48481890" display_start="48303751" display_stop="48481890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48877882" stop="49056025" display_start="48877882" display_stop="49056025" Strand="+" />
          </Location>
          <OMIM>614041</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000321.3(RB1):c.2520+1del</Name>
      <CanonicalSPDI>NC_000013.11:48473387:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48473388" stop="48473388" display_start="48473388" display_stop="48473388" variantLength="1" positionVCF="48473387" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="49047524" stop="49047524" display_start="49047524" display_stop="49047524" variantLength="1" positionVCF="49047523" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.49047527del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.49047527del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.48473391del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.48473391del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009009.1" sequenceAccession="NG_009009" sequenceVersion="1" change="g.174645del">
            <Expression>NG_009009.1:g.174645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001407165.1" sequenceAccession="NM_001407165" sequenceVersion="1" change="c.2520+1del">
            <Expression>NM_001407165.1:c.2520+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.3" sequenceAccession="NM_000321" sequenceVersion="3" change="c.2520+1del" MANESelect="true">
            <Expression>NM_000321.3:c.2520+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_517" sequenceAccession="LRG_517">
            <Expression>LRG_517:g.174645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_517t1" sequenceAccession="LRG_517t1">
            <Expression>LRG_517t1:c.2520+1del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA256698" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
        <XRef Type="rs" ID="587776779" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">PMID 2594029 notes that this variant can be interpreted as a single base deletion at the end of a coding exon or as a single base deletion affecting the adjacent splice site. The HGVS expression given reports the 3'-most position according to HGVS standards and, therefore, represents the latter case.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+1del AND Retinoblastoma" Accession="RCV000013944" Version="5">
        <ClassifiedConditionList TraitSetID="3557">
          <ClassifiedCondition DB="MedGen" ID="C0035335">Retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-05-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+1del AND Hereditary cancer-predisposing syndrome" Accession="RCV002426500" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-20" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-06-02">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2594029</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6463" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RETINOBLASTOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="614041.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
                <XRef ID="2161" DB="GeneTests" />
                <XRef ID="Retinoblastoma/6282" DB="Genetic Alliance" />
                <XRef ID="HP:0009919" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008380" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eye cancer, retinoblastoma</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RB1</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RB</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324949" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502479" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500108" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518780" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500594" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502581" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Both sporadic and heritable forms are tested.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors.</Attribute>
                <XRef ID="NBK1452" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7563" />
                <XRef ID="7563" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301625</ID>
                <ID Source="BookShelf">NBK1452</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">3061998</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <XRef ID="790" DB="Orphanet" />
              <XRef ID="C0035335" DB="MedGen" />
              <XRef ID="D012175" DB="MeSH" />
              <XRef ID="MONDO:0008380" DB="MONDO" />
              <XRef Type="MIM" ID="180200" DB="OMIM" />
              <XRef Type="primary" ID="HP:0009919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5225223" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8239307|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002741647" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2520+1delG intronic pathogenic mutation, located in intron 24 of the RB1 gene, results from a deletion of one nucleotide within intron 24 of the RB1 gene. This alteration has been observed in at least one individual with a personal and/or family history that is consistent with RB1-related disease (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and will result in the creation or strengthening of a novel splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.2520+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9794925" SubmissionDate="2024-05-29" DateLastUpdated="2024-06-02" DateCreated="2024-06-02">
        <ClinVarSubmissionID localKey="NM_000321.3:c.2520+1del|OMIM:180200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005046341" DateUpdated="2024-06-02" DateCreated="2024-06-02" Type="SCV" Version="1" SubmitterName="Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine" OrgID="1224" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Case and Pedigree Information: BILATERAL CASES:1, UNILATERAL CASES:1, TOTAL CASES:2, PEDIGREES:2. ACMG Codes Applied:PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.3:c.2520+1del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>RB12024</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="34191" SubmissionDate="2013-03-14" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614041.0001_RETINOBLASTOMA, SOMATIC" title="RB1, 1-BP DEL, 2657G_RETINOBLASTOMA, SOMATIC" />
        <ClinVarAccession Accession="SCV000034191" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1989-12-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a tumor from a patient (RB-2) with bilateral retinoblastoma (180200), Yandell et al. (1989) identified heterozygosity for a 1-bp deletion (2657delG) in exon 24 (which codes for amino acid 840) in the RB1 gene, which caused a frameshift and a new stop codon in exon 25. This was a somatic mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">2594029</ID>
              </Citation>
              <XRef DB="OMIM" ID="180200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <Name>RB1, 1-BP DEL, 2657G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2657G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614041.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RETINOBLASTOMA, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5225223" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9794925" TraitType="Disease" MappingType="XRef" MappingValue="180200" MappingRef="OMIM">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34191" TraitType="Disease" MappingType="Name" MappingValue="RETINOBLASTOMA, SOMATIC" MappingRef="Preferred">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

